ReviewCurrent atherosclerosis reports2026
Incidental Detection of Coronary Artery Calcification in Women Undergoing Cancer Screening or Treatment.
Review in Current atherosclerosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewCardiovascular disease and cancer are significant causes of morbidity and mortality. Cancer screening in woman provides an opportunity to detect early signs of cardiovascular disease. Women who undergo cancer screening or treatment may have imaging that directly visualizes the coronary arteries, presenting an opportunity to detect cardiovascular disease. This is particularly important in women without traditional cardiovascular risk factors who may be as low risk. This review aims to assess current evidence of the incidental detection of coronary artery calcification (CAC) in women undergoing cancer screening or treatment. RECENT
findingsCurrent evidence demonstrates that CAC is prevalent but underreported in this population. Elevated CAC scores are associated with increased cardiovascular mortality. There is also poor follow-up and post-detection management in cancer patients with evidence of CAC. Overall, the incidental detection of CAC allows for personalized risk stratification and reclassification. However, despite frequent detection, CAC is underreported and rarely translated into guideline-directed preventative care including lipid lowering therapies, antiplatelet agents, and additional workup, representing a critical gap, particularly in women.
Indexed as
Identifiers
42165928What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.